The DOI matches its Crossref record.
The enhancement effect of surfactants on the penetration of lorazepam through rat skin
Open accessAbstract
Lorazepam is an anxiolytic, antidepressant agent, having suitable feature for transdermal delivery. The percutaneous permeation of lorazepam was investigated in rat skin after application of a water:propylene glycol (50:50%v/v). The enhancing effects of various surfactants (sodium lauryl sulfate (SLS), cetyltrimethylammonium bromide (CTAB), benzalkonium chloride or Tween 80) with different concentrations on the permeation of lorazepam were evaluated using Franz diffusion cells fitted with rat skins. Flux, K(p), lag time and enhancement ratios (ERs) of lorazepam were measured over 24 h and compared with control sample. Furthermore, lorazepam solubility in presence of surfactants was determined. The in vitro permeation experiments with rat skin revealed that the surfactant enhancers varied in their ability to enhance the flux of lorazepam. The permeation profile of lorazepam in presence of the cationic surfactant, CTAB, reveals that an increase in the concentration of CTAB results in an increase in the flux of lorazepam in comparison with the control. But an increase in concentration of CTAB or benzalkounium chloride from 0.5 to 1% w/w or from 1 to 2.5% w/w resulted in a reduction in ER, respectively. Benzalkonium chloride which possessed the highest lipophilicity (logP=1.9) among cationic surfactants provided the greatest enhancement for lorazepam flux (7.66-fold over control) at 1% w/w of the surfactant. CTAB (logP<1) and sodium lauryl sulphate at a concentration of 5% w/w (the highest concentration) exhibited the greatest increase in flux of lorazepam compared with control (9.82 and 11.30-fold, respectively, over control). This is attributed to the damaging effect of the cationic and anionic surfactants on the skin at higher concentration. The results also showed that the highest ER was obtained in presence of 1% w/w surfactant with the exception of SLS and CTAB. The increase in flux at low enhancer concentrations is normally attributed to the ability of the surfactant molecules to penetrate the skin and increase its permeability. Reduction in the rate of transport of the drug present in enhancer systems beyond 1% w/w is attributed to the ability of the surfactant molecules to form micelles and is normally observed only if interaction between micelle and the drug occurs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Organogels and their use in drug delivery — A review
Vintiloiu, A., & Leroux, J.-C. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.09.014 · Cited by 740
Enhancement strategies for transdermal drug delivery systems: current trends and applications
Ramadon, D., McCrudden, M. T. C., Courtenay, A. J., & Donnelly, R. F. (2022) · Drug Delivery and Translational Research · doi:10.1007/s13346-021-00909-6 · Cited by 649
Enhancement of transdermal drug delivery via synergistic action of chemicals
Karande, P., & Mitragotri, S. (2009) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2009.08.015 · Cited by 399
Topical delivery of lipophilic drugs from o/w Pickering emulsions
Frelichowska, J., Bolzinger, M.-A., Pelletier, J., Valour, J.-P., & Chevalier, Y. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.12.017 · Cited by 318
Status of surfactants as penetration enhancers in transdermal drug delivery
Yasir, M., Som, I., & Bhatia, K. (2012) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/0975-7406.92724 · Cited by 303
Metadata
- Authors
- Nokhodchi, A., Shokri, J., Dashbolaghi, A., Hassan-Zadeh, D., Ghafourian, T., & Barzegar-Jalali, M.
- Venue
- International Journal of Pharmaceutics
- Publisher
- Elsevier BV
- Published
- 2003-01
- Volume
- 250
- Issue
- 2
- Pages
- 359-369
- ISSN
- 0378-5173 (ISSN-L)
- OpenAlex
- W2035962616
- Cited by
- 159
- References
- 0
- FWCI
- 5.60
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The enhancement effect of surfactants on the penetration of lorazepam through rat skin. https://app.cochat.ai/papers/10.1016/s0378-5173(02)00554-9
- The paper
- Nokhodchi, A., Shokri, J., Dashbolaghi, A., Hassan-Zadeh, D., Ghafourian, T., & Barzegar-Jalali, M. (2003). The enhancement effect of surfactants on the penetration of lorazepam through rat skin. International Journal of Pharmaceutics. https://doi.org/10.1016/s0378-5173(02)00554-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.